-
Overview
Lee has experienced anxiety for much of her adult life, but her symptoms have recently intensified—interfering with work, sleep, and daily functioning. Having previously trialled SSRIs with limited success, she is now exploring medical cannabis as a potential treatment option.
This case study follows Lee’s clinical assessment and treatment planning process, highlighting the key factors considered by her healthcare team in determining suitability for medical cannabis. Practitioners will examine how THC and CBD interact with anxiety symptoms, how patient history informs treatment planning, and what safety precautions are critical in minimising adverse effects—particularly with THC.
The module also explores regulatory considerations under the TGA framework and provides practical guidance on how to approach patient education and shared decision-making when discussing medical cannabis for anxiety management.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
- Discuss the relationship between THC, CBD and anxiety
- Discuss the TGA requirements, potential benefits and limitations of medical cannabis as a treatment option for anxiety
- Identify patients with anxiety who are suitable candidates for medical cannabis treatment
- Collect detailed patient information
- Apply critical safety considerations and provide patient education and treatment advice regarding medical cannabis treatment for anxiety
- Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management for anxiety
Overview
Lee has experienced anxiety for much of her adult life, but her symptoms have recently intensified—interfering with work, sleep, and daily functioning. Having previously trialled SSRIs with limited success, she is now exploring medical cannabis as a potential treatment option.
This case study follows Lee’s clinical assessment and treatment planning process, highlighting the key factors considered by her healthcare team in determining suitability for medical cannabis. Practitioners will examine how THC and CBD interact with anxiety symptoms, how patient history informs treatment planning, and what safety precautions are critical in minimising adverse effects—particularly with THC.
The module also explores regulatory considerations under the TGA framework and provides practical guidance on how to approach patient education and shared decision-making when discussing medical cannabis for anxiety management.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
- Discuss the relationship between THC, CBD and anxiety
- Discuss the TGA requirements, potential benefits and limitations of medical cannabis as a treatment option for anxiety
- Identify patients with anxiety who are suitable candidates for medical cannabis treatment
- Collect detailed patient information
- Apply critical safety considerations and provide patient education and treatment advice regarding medical cannabis treatment for anxiety
- Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management for anxiety